Reply to: Real‐World Predictors of Dupilumab Prescription in Patients With Chronic Rhinosinusitis With Nasal Polyps.

The article discusses the predictors of dupilumab prescription in patients with chronic rhinosinusitis with nasal polyps. The study, conducted by researchers from Vanderbilt University Medical Center and the University of Alabama-Birmingham, aimed to identify factors influencing the prescription of dupilumab. The study found that patients with higher postoperative SNOT-22 scores were more likely to be prescribed dupilumab, indicating a correlation between symptom severity and medication prescription. The researchers acknowledged limitations in their study design, such as the cross-sectional analysis and short follow-up timeframe, and suggested that further research with larger sample sizes and longer follow-up periods could provide more comprehensive insights into dupilumab prescription trends. [Extracted from the article]